Detalhe da pesquisa
1.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
N Engl J Med
; 389(26): 2436-2445, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921461
2.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931634
3.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 384(17): 1601-1612, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913638
4.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med
; 384(17): 1589-1600, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913637
5.
Comparative Levels of Urinary Biomarkers of Renal Injury and Inflammation Among Patients With Diabetic Nephropathy With or Without Hyperuricemia.
J Clin Rheumatol
; 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38351500
6.
IgA nephropathy: the lectin pathway and implications for targeted therapy.
Kidney Int
; 104(2): 254-264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263354
7.
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan.
Am J Nephrol
; 53(10): 675-686, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404708
8.
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
Am J Nephrol
; 53(10): 687-700, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423588
9.
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
Am J Hematol
; 97(9): 1178-1188, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751858
10.
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
Am J Respir Crit Care Med
; 202(9): 1253-1261, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32609011
11.
Angiotensin II for the Treatment of Vasodilatory Shock.
N Engl J Med
; 377(5): 419-430, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28528561
12.
Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.
Rev Cardiovasc Med
; 21(1): 1-7, 2020 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259899
13.
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Kidney Int
; 95(1): 219-231, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420324
14.
A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.
Blood
; 129(7): 896-905, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864296
15.
Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study.
BMC Nephrol
; 20(1): 80, 2019 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836948
16.
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Crit Care Med
; 46(6): 949-957, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509568
17.
Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Am J Nephrol
; 47 Suppl 1: 14-29, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29852493
18.
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
Nephrol Dial Transplant
; 33(11): 1950-1959, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481660
19.
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.
J Am Soc Nephrol
; 28(4): 1306-1313, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821627
20.
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
J Am Soc Nephrol
; 26(8): 2023-31, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655065